CI Early Look vs Neuro
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CI Early Look
Read full descriptionHide full description
Clinical Ink Early Look is an easy-to-use app designed to make it easier to be a participant in a clinical study. You can download and use it on your own Apple iOS smartphone. Depending on the study, Early Look may provide some or all of the following capabilities: · Reminders about your appointments via a text message or directly within the app · Assistance with addresses and/or directions for your upcoming visits · Reminders to take medications or perform tasks that are part of your clinical study · Relevant videos or content to help you understand more about the study that you are part of, or to help you prepare for upcoming tasks or appointments · Questionnaires about how you are feeling or about performing trial tasks · Feedback about your performance on study tasks If you have any trouble downloading or using this app, please contact your Clinical Ink Project Manager.
Neuro
Access essential medical literature on neuro-oncology, including randomized trials, in an easy-to-read format. Quickly review seminal studies and update your knowledge on the surgical and medical management of central nervous system tumors.
- Review randomized controlled trials
- Easy-to-read format
- Access seminal studies
- Covers surgical and medical management
- Includes citation information
- Content updated 1-3 months
Read full descriptionHide full description
Neuro-oncology: What's the data?, 3rd edition This is the app that puts the power of knowledge in the palm of your hand! Essential literature, including a voluminous body of randomized, controlled trials, is reviewed and presented in an easy-to-read format. The user can review seminal studies on a topic in seconds. Staff surgeons, review and update your knowledge quickly, between clinic patients, if necessary! Residents and medical students, get bulletproof protection from unpleasant pimp sessions! PAs and NPs, get the information you need, fast! Over three hundred references are included, covering topics in the major areas of surgical and medical management of tumors of the central nervous system. Citation information is included, permitting the user to pursue additional, in-depth study. No matter what your level of training or expertise, this app can make you better! Users should be aware that the content of this app overlaps with that of another app, entitled "Neurosurgery: What’s the data?", which covers the breadth of neurosurgery. ------------------------------------------------------------------------------------------ The annual subscription fee is $1.99. This is an auto-renewing subscription app - content is updated every 1-3 months Payment information will be verified at time of purchase; if subscription is not cancelled before the end of the 3-day free trial, your credit card will be charged. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Account will be charged for renewal within 24-hours prior to the end of the current period, and identify the cost of the renewal. Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase. Terms of Use: https://whatsthedata.com/terms-of-use Privacy policy: https://whatsthedata.com/privacy-policy
Screenshots
Verdict
The clearest difference is in-app purchases: CI Early Look at none against Neuro's 1. CI Early Look also leads on update cadence (every 2 months vs every 26 months) and iOS requirement (10.0 vs 16.6). On price, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neuro sells 1 in-app purchase, starting at $1.99 per year. CI Early Look asks for nothing beyond the download.
CI Early Look ships an update every 2 months, Neuro every 26 months. The most recent releases landed on March 1, 2026 and August 13, 2026 respectively.
| Parameter | CI Early Look | Neuro |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (6 ratings) — better |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | — | 6 — better |
| Update frequency | Every 2 months — better | Every 26 months |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | — | Subscription |
| Devices | iPhone, iPod — better | iPhone |
| Requires iOS | 10.0 — better | 16.6 |
| Further details — not scored | ||
| Size | 31 MB | 20 MB |
| Age rating | 12+ | 12+ |
| Developer | Clinical Ink, Inc | Limbix LLC |
In-app purchases
CI Early Look
No in-app purchases
Neuro
- Annual Subscription3 Days trial$1.991 Year








